Management

Dr Anthony Gilbert joined Retroscreen Virology Ltd in October 2007 as Medical Director.

Dr Gilbert lends a unique blend of medical expertise, both from his NHS clinical experience and from his clinical research background. His professional activities have included work in pain research and vaccine and antiviral research. Having led numerous studies in London's teaching hospitals to Good Clinical Practice guidelines, he focuses on clinic development through evidence-based practice.

Dr Gilbert earned his Bachelor of Medicine and Bachelor of Surgery from the University of the Witwatersrand, Johannesburg. He is a member of the Institute of Clinical Research and has been appointed as an expert member of the Royal National Orthopaedic Hospital/Institute of Musculoskeletal Sciences Local Research Ethics Committee.

Roberta was appointed Director of Quality in February 2008. A science graduate with more than 16 years experience within the Pharmaceutical and Biotechnology industries. Roberta is a highly experienced specialist in establishing and maintaining effective quality functions and systems.

Roberta has previously worked in Kinnerton, ICON, Pfizer, Bayerand Elan in positions of increasing responsibility and Seniority and most recently was Interim Director R&D QA at Stiefel Laboratories.

Alex Mann is the Head of IP, Research & Development and is a Senior Research Scientist. His activities also include leading EU grants and R&D within the company.

Alex joined Retroscreen in 1999 after completing a Medical Microbiology masters degree at Barts and the London Hospital, Queen Mary. Initially as a Research Scientist he took on additional roles in Project and Operational management. More recently Alex has moved from heading Operations to head a new arm of the company as Head of IP, Research & Development. He has extensively worked with Influenza and other respiratory viruses from the invitro stage to the human challenge and immunogenicity models. He has extensive experience in Influenza, RSV, HSV, SARS, Rotavirus and Norovirus.

Sumitava Dutta started his career at a world renowned CRO, working as a Study Director in Pre-Clinical and Clinical Metabolism studies. After successful completion of training, Sumitava moved on to working with GlaxoSmithKline Pharmaceuticals specialising in microdialysis and electrochemical detection. After the restructuring of this company he returned to the contract research sector where he became a Senior Study Director with specialist interest in HPLC and LC-MS/MS in tandem with radiodetection. Continuing in contract research Sumitava joined a new start up company helping them to grow and became heavily involved in operations at director level in the metabolism area.

Sumitava has been heavily involved in GLP, GCP and GMP compliance standards throughout his career.  In addition, he has made numerous regulatory dossier submissions to regulatory bodies such as the MHRA, FDA and raporteur states for a variety of companies ranging from venture capital to major pharmaceutical companies.